India Satisfied With Change In WHO Counterfeit Drug Definition
This article was originally published in PharmAsia News
Executive Summary
Indian authorities appear to have put to rest fears the products of Indian drug makers would be labeled counterfeit under a new UN agency rule. The World Health Organization-funded agency had proposed a definition that would have identified counterfeits as those with a "false representation about their identity, history or source." Indian representatives argued at the WHO such a definition could include legitimate generics. Surinder Singh, the Drug Controller General of India, said the WHO has agreed to drop the word "history" from the definition, addressing a major Indian complaint, but that intellectual property right and trademark issues remain problems for the government. (Click here for more